Education
About Us
Working with TipRanks
Follow Us
Star Health & Allied Insurance Co. Ltd. (IN:STARHEALTH)
:STARHEALTH
STARHEALTH Stock Chart & Stats
₹459.75
-₹6.80(-1.41%)
At close: 4:00 PM EST
₹459.75
-₹6.80(-1.41%)
Day’s Range― - ―
52-Week Range₹330.05 - ₹533.90
Previous CloseN/A
Volume276.82K
Average Volume (3M)42.40K
Market Cap
₹268.90B
Enterprise Value₹267.63B
Total Cash (Recent Filing)₹0.00
Total Debt (Recent Filing)₹4.70B
Price to Earnings (P/E)52.2
Beta0.79
Next Earnings
Apr 24, 2026EPS Estimate
0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.20
Shares Outstanding588,398,800
10 Day Avg. Volume41,268
30 Day Avg. Volume42,396
Financial Highlights & Ratios
PEG Ratio-1.33
Price to Book (P/B)2.88
Price to Sales (P/S)1.24
P/FCF Ratio15.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.12
Revenue Forecast (FY)₹187.34B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained ~21.7% revenue growth indicates durable premium expansion and market traction in retail and group health lines. Persistent top-line growth supports scale, helps spread fixed costs, and provides a larger underwriting float for investment income over the medium term.
Cash GenerationOperating cash flow consistently outpacing net income and rising free cash flow show strong cash conversion from underwriting and investment operations. This enhances liquidity for claims, supports regulatory reserves, funds growth initiatives, and reduces reliance on external financing.
Balance Sheet StrengthMaterial deleveraging to a 0.07 debt/equity and a positive ROE reflect improved financial solidity and capital efficiency. Lower leverage reduces solvency risk from large claims or cyclical shocks and increases headroom to meet regulatory capital requirements over the coming months.
Bears Say
Earnings VolatilityLarge negative EPS growth implies earnings remain variable, likely driven by underwriting cycles, claim volatility, or investment mark-to-market swings. Such volatility complicates capital planning, hinders predictable return generation, and can limit ability to sustainably raise retained earnings.
Legacy Underwriting WeaknessPrior periods of negative operating margins and historically elevated leverage demonstrate the company faced structural underwriting and cost-control challenges. If pricing, claims management, or loss ratios deteriorate, past weaknesses could re-emerge and pressure medium-term profitability.
Claims & Medical Inflation RiskAs a stand-alone health insurer, profitability is structurally exposed to rising medical costs, claim frequency/severity, and fraud. These factors can erode margins and force higher premiums or reinsurance costs, constraining underwriting results and long-term margin sustainability.
Star Health & Allied Insurance Co. Ltd. News
STARHEALTH FAQ
What was Star Health & Allied Insurance Co. Ltd.’s price range in the past 12 months?
Star Health & Allied Insurance Co. Ltd. lowest stock price was ₹330.05 and its highest was ₹533.90 in the past 12 months.
What is Star Health & Allied Insurance Co. Ltd.’s market cap?
Star Health & Allied Insurance Co. Ltd.’s market cap is ₹268.90B.
When is Star Health & Allied Insurance Co. Ltd.’s upcoming earnings report date?
Star Health & Allied Insurance Co. Ltd.’s upcoming earnings report date is Apr 24, 2026 which is in 37 days.
How were Star Health & Allied Insurance Co. Ltd.’s earnings last quarter?
Star Health & Allied Insurance Co. Ltd. released its earnings results on Jan 28, 2026. The company reported ₹2.2 earnings per share for the quarter, missing the consensus estimate of ₹2.422 by -₹0.222.
Is Star Health & Allied Insurance Co. Ltd. overvalued?
According to Wall Street analysts Star Health & Allied Insurance Co. Ltd.’s price is currently Overvalued.
Does Star Health & Allied Insurance Co. Ltd. pay dividends?
Star Health & Allied Insurance Co. Ltd. does not currently pay dividends.
What is Star Health & Allied Insurance Co. Ltd.’s EPS estimate?
Star Health & Allied Insurance Co. Ltd.’s EPS estimate is 0.41.
How many shares outstanding does Star Health & Allied Insurance Co. Ltd. have?
Star Health & Allied Insurance Co. Ltd. has 588,398,800 shares outstanding.
What happened to Star Health & Allied Insurance Co. Ltd.’s price movement after its last earnings report?
Star Health & Allied Insurance Co. Ltd. reported an EPS of ₹2.2 in its last earnings report, missing expectations of ₹2.422. Following the earnings report the stock price went up 3.414%.
Which hedge fund is a major shareholder of Star Health & Allied Insurance Co. Ltd.?
Currently, no hedge funds are holding shares in IN:STARHEALTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Star Health & Allied Insurance Co. Ltd.
Star Health and Allied Insurance Company Limited provides health insurance products. It offers retail health products to various customer segments, including individuals, families, students, and senior citizens, as well as persons with pre-existing medical conditions across the middle-market customer segment; and group health insurance policies provide to employees of corporates, including SMEs through company health insurance plans. The company also provides personal accident and travel insurance. It distributes its products through individual agents, brokers, corporate agent banks, other corporate agents, and online channel partners comprising web aggregators, as well as directly to customers. As of September 30, 2021, the company had 779 health insurance branches across 25 states and 5 union territories in India. Star Health and Allied Insurance Company Limited was incorporated in 2005 and is based in Chennai, India.
Technical Analysis
Alembic Pharmaceuticals Limited
―
HealthCare Global Enterprises Ltd.
―
Marksans Pharma Limited
―
Global Health Limited
―
Medi Assist Healthcare Services Limited
―